Cargando…

Clinical Characteristics of Metastatic Colorectal Cancer Combined with Gastrointestinal Perforation and Prognostic Value of Circulating Tumor DNA

OBJECTIVE: To explore the clinical characteristics of metastatic colorectal cancer combined with gastrointestinal perforation and the prognostic value of circulating tumor DNA (ctDNA). METHODS: A total of 97 patients with metastatic colorectal cancer and gastrointestinal perforation were enrolled as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hong, Rong, Dongwen, Yang, Wenhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256445/ https://www.ncbi.nlm.nih.gov/pubmed/35800188 http://dx.doi.org/10.1155/2022/6989583

Ejemplares similares

Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2023)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Gastrointestinal Perforation With an Intraluminal Stent and Bevacizumab use in Advanced Metastatic Colorectal Cancer
por: Akeel, Nouf, et al.
Publicado: (2021)

Meta-analysis of the prognostic value of circulating tumor cells in gastrointestinal cancer
por: Yao, Yuming, et al.
Publicado: (2022)

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
por: Patelli, Giorgio, et al.
Publicado: (2023)

The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma
por: Boerlin, Aurelio, et al.
Publicado: (2022)

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
por: Magri, Valentina, et al.
Publicado: (2023)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis
por: He, Yiping, et al.
Publicado: (2020)

MDCT Findings in Gastrointestinal Perforations and the Predictive Value according to the Site of Perforation
por: Romano, Stefania, et al.
Publicado: (2022)

The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis
por: Basnet, Shiva, et al.
Publicado: (2016)

Predictive and prognostic value of circulating blood lymphocyte subsets in metastatic breast cancer
por: Yang, Jian, et al.
Publicado: (2019)

Prognostic value of circulating tumor DNA in patients with colon cancer: Systematic review
por: Fan, Gaowei, et al.
Publicado: (2017)

The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment
por: Ma, Shenglin, et al.
Publicado: (2021)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

Circulating tumor DNA applications in monitoring the treatment of metastatic colorectal cancer patients
por: Kazemifard, Nesa, et al.
Publicado: (2019)

Circulating tumor DNA as a therapy response marker in metastatic colorectal cancer
por: Ma, Xiaoju Max, et al.
Publicado: (2022)

Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer
por: Lee, Dae-Won, et al.
Publicado: (2023)

Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
por: de Albuquerque, Andreia, et al.
Publicado: (2012)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Identification of Atypical Circulating Tumor Cells with Prognostic Value in Metastatic Breast Cancer Patients
por: Lopresti, Alexia, et al.
Publicado: (2022)

Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

DNA duplication is essential for the repair of gastrointestinal perforation in the insect midgut
por: Huang, Wuren, et al.
Publicado: (2016)

Circulating tumor DNA analysis of metastatic renal cell carcinoma
por: Zhang, Jingbo, et al.
Publicado: (2021)

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer
por: Thomsen, Caroline B., et al.
Publicado: (2020)

Genetic features and therapeutic relevance of emergent circulating tumor DNA alterations in refractory non-colorectal gastrointestinal cancers
por: Hsiehchen, David, et al.
Publicado: (2022)

Corrigendum: Longitudinal Circulating Tumor DNA Profiling in Metastatic Colorectal Cancer During Anti-EGFR Therapy
por: Yang, Wentao, et al.
Publicado: (2022)

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
por: Schraa, Suzanna J., et al.
Publicado: (2022)

The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
por: Lu, Yuanyuan, et al.
Publicado: (2021)

Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients
por: Jing, Chen, et al.
Publicado: (2016)

Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer
por: Lu, Yan-jun, et al.
Publicado: (2017)

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
por: Amatu, Alessio, et al.
Publicado: (2019)

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
por: Salvianti, Francesca, et al.
Publicado: (2021)

Prognostic Value of Circulating IGFBP2 and Related Autoantibodies in Children with Metastatic Rhabdomyosarcomas
por: Poli, Elena, et al.
Publicado: (2020)

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma
por: Wintachai, Preawwalee, et al.
Publicado: (2021)

Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
por: Ucar, Gokhan, et al.
Publicado: (2020)

Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients
por: Galbiati, Silvia, et al.
Publicado: (2021)

Significance of postoperative follow-up of patients with metastatic colorectal cancer using circulating tumor DNA
por: Benešová, Lucie, et al.
Publicado: (2019)

Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2021)

Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer
por: Barbazan, Jorge, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_latts6ken0jdrnl7om0dkbed7g